Morschhauser, F., Feugier, P., Flinn, I. W., Gasiorowski, R., Greil, R., Illés, Á., . . . Zelenetz, A. D. (2021). A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma. Blood.
Chicago Style citaatMorschhauser, Franck, et al. "A Phase 2 Study of Venetoclax Plus R-CHOP As First-line Treatment for Patients With Diffuse Large B-cell Lymphoma." Blood 2021.
MLA citatieMorschhauser, Franck, et al. "A Phase 2 Study of Venetoclax Plus R-CHOP As First-line Treatment for Patients With Diffuse Large B-cell Lymphoma." Blood 2021.
Let op: Deze citaties zijn niet altijd 100% accuraat.